METTL3 and oral cavity squamous cell carcinoma: METTL3 can modify fibroblast growth factor receptor (FGFR3, an anlotinib target) m6 A methylation in oral squamous cell carcinoma (OSCC), and the knockdown of METTL3 enhances anlotinib sensitivity of OSCC cells [273].